ELEGANCIA LIFESCIENCES
LIVE

Serial Number

79423964

Owner

Hanane CHAJRA

Attorney

Brian Schar

Filing Date

Mar 24, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ELEGANCIA LIFESCIENCES Trademark

Serial Number: 79423964 • Registration: 8155769

ELEGANCIA LIFESCIENCES is a trademark filed by Hanane CHAJRA on March 24, 2025. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Hanane CHAJRA

26 rue des Tonnelles

Entity Type: 98

Trademark Details

Filing Date

March 24, 2025

Registration Date

March 3, 2026

Published for Opposition

January 13, 2026

Goods & Services

Training in the field of cosmetics, medical devices, pharmaceuticals, and food supplements; organization of training sessions in the field of cosmetics, medical devices, pharmaceuticals, and food supplements; vocational training in the field of cosmetics, medical devices, pharmaceuticals, and food supplements; training and teaching in the field of cosmetics, medical devices, pharmaceuticals, and food supplements; training courses in the field of science; organization and conducting of conferences in the field of cosmetics, medical devices, pharmaceuticals, and food supplements; organization and conducting of seminars in the field of cosmetics, medical devices, pharmaceuticals, and food supplements; organization and conducting of training seminars in the field of cosmetics, medical devices, pharmaceuticals, and food supplements; organization and conducting of symposiums in the field of pharmaceuticals and medical devices cosmetics, medical devices, pharmaceuticals, and food supplements; preparation, coordination and organization of conferences in the field of cosmetics, medical devices, pharmaceuticals, and food supplements

Scientific-technological services, namely, pharmaceutical research and development services, technical writing services in the nature of scientific communication, poster preparation, article redaction, data analysis, and preparation of technical reports, and claim substantiation services being scientific research; scientific research; biological research; biochemical research; cosmetic research; clinical research in the field of cosmetics, medical devices, and drug development; scientific research in bacteriology; information about scientific research in the field of biochemistry and biotechnology; scientific research and development; biological research consultancy; scientific analyses in the field of molecular biology; scientific and technological services, namely, pharmaceutical research and development services, technical writing services in the nature of scientific communication, poster preparation, article redaction, data analysis, and preparation of technical reports, and claim substantiation services being scientific research services; quality control for others; technical project study, namely, conducting scientific feasibility studies for others in the field of cosmetics, medical devices, pharmaceuticals, and food supplements; technical project study services, namely, conducting scientific feasibility studies in the field of cosmetics, medical devices, pharmaceuticals, and food supplements; technical research projects and studies, namely, conducting scientific feasibility studies for others in the field of cosmetics, medical devices, pharmaceuticals, and food supplements; research and development of new products for third parties; cosmetics research, namely, research relating to cosmetic products for others; consultancy with respect to pharmaceutical research and development; consultancy in the field of pharmaceutical research; provision of medical and scientific research information concerning the results of clinical trials for pharmaceutical products; medical and scientific research, namely, carrying out clinical trials for pharmaceutical products for others; biological and medical research; research and development in the field of pharmaceuticals and biotechnology; research and development for the pharmaceutical industry, namely, research and development in the field of pharmaceuticals; cell culture services for others for scientific research purposes and for scientific research for third parties; cell culture for others for scientific research purposes; scientific research, namely, preparation of biological samples for research purposes; medical and pharmacological research services; stem cell research; scientific research services with respect to the isolation and cultivation of human cells and tissues; research and development in the field of microorganisms and cells; scientific research on induced pluripotent stem cells

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 10, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 24, 2026 FICS
FINAL DISPOSITION PROCESSED
Aug 24, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 3, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 3, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 3, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 13, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jan 13, 2026 PUBO
NOTIFICATION PROCESSED BY IB
Jan 8, 2026 GPNX
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 7, 2026 NONP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 24, 2025 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 23, 2025 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 11, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 11, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 11, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 11, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 11, 2025 CNEA
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Dec 9, 2025 RDX3
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Dec 9, 2025 RDX1
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Dec 9, 2025 RRDX
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 1, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 1, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 1, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 28, 2025 GNFN
FINAL REFUSAL E-MAILED
Nov 28, 2025 GNFR
FINAL REFUSAL WRITTEN
Nov 28, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 10, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 10, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 10, 2025 TROA
REFUSAL PROCESSED BY IB
Oct 24, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 8, 2025 RFCS
REFUSAL PROCESSED BY MPU
Oct 8, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 26, 2025 RFCR
NON-FINAL ACTION WRITTEN
Aug 25, 2025 CNRT
ASSIGNED TO EXAMINER
Aug 21, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
May 23, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 23, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 22, 2025 REPR